Novo Nordisk | NVO - Stammkapital





Stammkapital Veränderung Datum
ANI Pharmaceuticals USD 22.49M 760K 2025-12
Aurora Cannabis CAD 58.95M 2.24M 2026-03
Bausch Health Companies USD 373.9M 436K 2026-06
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Canopy Growth CAD 422.07M 53.78M 2026-03
Corcept Therapeutics USD 107.33M 1.36M 2026-03
Drreddys Laboratories INR 832.69M 123K 2026-03
Eli Lilly USD 943.5M 3.33M 2026-03
GlaxoSmithKline GBP 4.08B 20.6M 2026-06
Merck USD 2.47B 4.93M 2026-03
Nektar Therapeutics USD 29.47M 9.09M 2026-03
Novartis USD 1.9B 7.38M 2026-06
Novo Nordisk DKK 4.43B 13.25M 2026-06
Novo Nordisk DKK 4.43B 13.25M 2026-06
Pacira USD 39.82M 512K 2026-06
Perrigo USD 138.1M 500K 2026-03
Phibro Animal Health USD 40.48M 0 2025-12
Prestige Brands USD 47.37M 53K 2026-06
Sanofi EUR 1.21B 8.25M 2026-03
Supernus Pharmaceuticals USD 58.16M 124K 2026-06
Zoetis USD 414.15M 6.19M 2026-06